September 7, 2021 – A Toronto healthtech startup reinventing pain management has been named one of eight finalists in the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health companies to tackle some of North America’s greatest health challenges.
The only Canadian company to crack the finals, Phyxable is an end-to-end pain and prevention platform. With the help of telemedicine, augmented reality, and machine learning, Phyxable empowers people in pain to quickly diagnose, self-care and prevent their injuries from coming back without stepping outside of their home.
“There is such exciting innovation and talent in the Canadian healthtech space, and that shone through in the entries to this year’s Accenture HealthTech Innovation Challenge. More Canadian startups applied than ever before, and for the first time Canada will be represented among the finalists with Phyxable, a remarkable startup reinventing pain management. Accenture also recognized two notable Canadian disruptors: League, ‘The Next HealthTech Unicorn’ and Gray Oncology, a ‘Rising Star’. Together these companies are helping drive digital healthcare transformation in Canada and solve some of North America’s greatest health challenges.” – Jimmy Yang, Canadian health practice lead at Accenture
Phyxable will participate in the Accenture HealthTech Innovation Challenge final round and awards ceremony at a virtual event on September 28, 2021. The judging panel will comprise executives from globally recognized health and venture capital companies, providing the finalists with exposure and access to industry-leading experience to help bring their ideas to market.
Click the link below to learn more about the Accenture HealthTech Innovation Challenge.
